slide_bg

Precision Medicine

Developing treatments intended to reduce
cardiovascular events in a genetically
distinct subset of patients.

DalCor Pharmaceuticals’ latest press releases.

Welcome to DalCor Pharmaceuticals

DalCor is focused on providing precision medicine through identification of genetically distinct patient populations that derive clinical benefits. By integrating clinical, biologic and genetic insights, DalCor intends to deliver superior outcomes in clinical medicine.

The Drug: Dalcetrapib

Research / Data

About Dalcor

The dal-GenE study

To prospectively confirm the cardiovascular outcomes improvement seen in the genetic subpopulation of the dal-Outcomes study DalCor will sponsor a new one that will comprise…

of

5000

Patients

in

30

Countries

over

12

Months